The measurements taken by the spirometry device are used to generate a pneumotachograph that can help to assess lung conditions such as: asthma, pulmonary fibrosis, cystic fibrosis, and chronic obstructive pulmonary disease. We use the test results to diagnose bronchial hyperresponsiveness to exercise, cold air, or pharmaceutical agents.
Aerocrine is a medical technology company focused on improving the treatment of patients with inflamed airways. Measuring airways inflammation helps doctors to diagnose, monitor and optimize therapy for people with inflammatory airway diseases (Asthma).
People with asthma have an underlying condition in their lungs. Their airways, which are rather like hollow branches that bring air into the lungs, are always inflamed are easily irritated by outside triggers. One common cause is exposure to allergens in patients with an allergy.
When this happens, the airways contract and narrow. The cells in the irritated airways also produce more mucus or phlegm, making the airway even smaller. Breathing becomes difficult and that is what is often called an asthma attack.
Aerocrine offers versatile, easy-to-use exhaled nitric oxide (NO) monitoring devices for research and clinical applications. All Aerocrine devices use highly accurate methods for measuring minute concentrations of NO, and incorporate NO scrubbers that eliminate atmospheric NO from the patient’s breath. All products comply with international guidelines and are CE-marked for routine clinical use and 510(k) cleared by FDA.
Shape-HF results are validated, simple to interpret and reproducible. The system is perfect for serial testing, allowing physicians to track patient progress over time.
The Shape-HF is easy on patients too. Evidence-based results can be obtained using low-intensity, graded or steady state testing protocols. The system avoids undue stress on the heart failure patient; they can fully perform the test and even high-risk patients can easily be tested with little or no discomfort.